Answers are grounded in this paper and cite their sources.
Previously, we proposed a hypothesis that ladderanes could mimic ortho-benzene in bioactive compounds. In this work, we have proven this hypothesis experimentally. In particular, 2,3-disubstituted ladderanes were efficiently synthesized and extensively characterized. These cores were then incorporated into six bioactive compounds instead of the benzene ring. The corresponding patent-free ladderane derivatives of Thalidomide and Oxatomide showed improved physicochemical profiles and similar biological activities compared to those of the original drugs. These results confirm that ladderanes can act as saturated bioisosteres of ortho-benzenes.
No takes yet. Share an insight, caveat, or question.
Datsenko et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: